J. Safra Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$214K Buy
436
+31
+8% +$16.8K 0.01% 213
2025
Q4
$235K Buy
405
+220
+119% +$124K 0.01% 206
2025
Q3
$89.7K Sell
185
-152
-45% -$70.8K 0.01% 199
2025
Q2
$137K Sell
337
-109
-24% -$45.6K 0.01% 173
2025
Q1
$222K Buy
446
+153
+52% +$82.9K 0.02% 135
2024
Q4
$152K Buy
293
+1
+0.3% +$550 0.01% 143
2024
Q3
$179K Buy
292
+2
+0.7% +$1.18K 0.02% 83
2024
Q2
$160K Hold
290
0.02% 69
2024
Q1
$169K Hold
290
0.02% 50
2023
Q4
$154K Hold
290
0.02% 49
2023
Q3
$147K Hold
290
0.02% 52
2023
Q2
$151K Hold
290
0.02% 59
2023
Q1
$167K Buy
+290
New +$163K 0.03% 54
2022
Q4
Sell
-219
Closed 128
2022
Q3
$0 Buy
219
+62
+39% +$34.7K ﹤0.01% 93
2022
Q2
$0 Sell
157
-14
-8% -$7.71K ﹤0.01% 136
2022
Q1
$0 Buy
+171
New +$98.2K ﹤0.01% 137

Other funds holding TMO

J. Safra Asset Management's TMO Position: Q1 2026 in Review

J. Safra Asset Management increased its Thermo Fisher Scientific (TMO) stake by 7.7% in Q1 2026, buying an estimated $16.8K and bringing the position to 436 shares worth $214K. The position accounts for 0.01% of the portfolio, ranked #213.

J. Safra Asset Management first reported a position in TMO in Q1 2022 and has held it in 16 quarters since. The position peaked at $235K in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • J. Safra Asset Management held 436 shares of Thermo Fisher Scientific worth $214K as of Q1 2026.
  • J. Safra Asset Management bought 31 Thermo Fisher Scientific shares in Q1 2026, an estimated $16.8K.
  • Thermo Fisher Scientific made up 0.01% of J. Safra Asset Management's portfolio in Q1 2026, its #213 holding.
  • J. Safra Asset Management first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 16 quarters since.
  • J. Safra Asset Management's Thermo Fisher Scientific position peaked at $235K in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on J. Safra Asset Management's 13F filing for Q1 2026, filed 4 May 2026.